From: Recent advances in extracellular vesicle engineering and its applications to regenerative medicine
No. | EV source | Method | Loading material | Ref. |
---|---|---|---|---|
1 | HepG2 Cell | Incubation | Bleomycin | [97] |
2 | MDA-MB-231 cell | Incubation | lactoferrin | [98] |
3 | Dendritic cell | Incubation | triptolide | [99] |
4 | ADMSC | Incubation | Ovalbumin | [100] |
5 | ADMSC | Incubation | Coenzyme Q10 | [103] |
6 | HT92 Cell | Active incubation | Doxorubicin | [104] |
7 | neutrophil | Extrusion | Doxorubicin | [108] |
8 | bEnd.3 cell | Sonication | Doxorubicin | [110] |
9 | RAW 264.7 | Sonication | Resveratrol | [113] |
10 | M2 macrophage | Sonication | Melatonin | [114] |
11 | M2 macrophage | Sonication | Berberine | [111] |
12 | J774A.1 cell | Sonication | Curcumin | [115] |
13 | RAW 264.7 | Sonication | Baicalin | [116] |
14 | HEK293T | Sonication | Erastin/Rose Bengal | [112] |
15 | Plasma | Sonication | Quercetin | [117] |
16 | lens epithelial cell | Electroporation | Doxorubicin | [121] |
17 | Urine | Electroporation | Au NP | [118] |
18 | Urine | Electroporation | PMA/Fe-HSA@DOX | [119] |
19 | UCMSC | Electroporation | miR-29b mimic | [123] |
20 | BMSC | Electroporation | siRNA | [120] |
21 | BMSC | Electroporation | Rifampicin | [124] |
22 | BMSC | Freeze-thaw, Incubation, Active incubation, Sonication | bevacizumab | [107] |
23 | hEnSC | Freeze-thaw, Incubation, Active incubation, Sonication | Atorvastatin | [105] |
24 | Cabbage | Incubation, lipofectamin | Doxorubicin | [125] |
25 | UCMSC | Incubation, Freeze-thaw, Extrusion | Paclitaxel | [109] |
26 | Milk | Incubation, Sonication | Doxorubicin | [126] |
27 | Panc-1 cell | Incubation, Sonication | Gemcitabine | [127] |
28 | Milk | Incubation, Active incubation, Sonication | Doxorubicin | [106] |